Literature DB >> 19935883

Inhibition of Hes1 activity in gall bladder epithelial cells promotes insulin expression and glucose responsiveness.

R A Coad1, J R Dutton, D Tosh, J M W Slack.   

Abstract

The biliary system has a close developmental relationship with the pancreas, evidenced by the natural occurrence of small numbers of biliary-derived beta-cells in the biliary system and by the replacement of biliary epithelium with pancreatic tissue in mice lacking the transcription factor Hes1. In normal pancreatic development, Hes1 is known to repress endocrine cell formation. Here we show that glucose-responsive insulin secretion can be induced in biliary epithelial cells when activity of the transcription factor Hes1 is antagonised. We describe a new culture system for adult murine gall bladder epithelial cells (GBECs), free from fibroblast contamination. We show that Hes1 is expressed both in adult murine gall bladder and in cultured GBECs. We have created a new dominant negative Hes1 (DeltaHes1) by removal of the DNA-binding domain, and show that it antagonises Hes1 function in vivo. When DeltaHes1 is introduced into the GBEC it causes expression of insulin RNA and protein. Furthermore, it confers upon the cells the ability to secrete insulin following exposure to increased external glucose. GBEC cultures are induced to express a wider range of mature beta cell markers when co-transduced with DeltaHes1 and the pancreatic transcription factor Pdx1. Introduction of DeltaHes1 and Pdx1 can therefore initiate a partial respecification of phenotype from biliary epithelial cell towards the pancreatic beta cell.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19935883     DOI: 10.1139/o09-063

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  6 in total

Review 1.  Regenerative medicine and cell-based approaches to restore pancreatic function.

Authors:  Cara Ellis; Adam Ramzy; Timothy J Kieffer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-16       Impact factor: 46.802

2.  Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.

Authors:  Dian-cai Zhang; Jin-long Liu; Yong-bin Ding; Jian-guo Xia; Guo-yu Chen
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

3.  Novel surface markers directed against adult human gallbladder.

Authors:  Feorillo H Galivo; Craig Dorrell; Maria T Grompe; YongPing Zhong; Philip R Streeter; Markus Grompe
Journal:  Stem Cell Res       Date:  2015-06-11       Impact factor: 2.020

4.  Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming.

Authors:  Raymond D Hickey; Feorillo Galivo; Jonathan Schug; Michael A Brehm; Annelise Haft; Yuhan Wang; Eric Benedetti; Guoqiang Gu; Mark A Magnuson; Leonard D Shultz; Eric Lagasse; Dale L Greiner; Klaus H Kaestner; Markus Grompe
Journal:  Stem Cell Res       Date:  2013-02-18       Impact factor: 2.020

5.  Reprogramming human gallbladder cells into insulin-producing β-like cells.

Authors:  Feorillo Galivo; Eric Benedetti; Yuhan Wang; Carl Pelz; Jonathan Schug; Klaus H Kaestner; Markus Grompe
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

6.  A Pro-Endocrine Pancreatic Islet Transcriptional Program Established During Development Is Retained in Human Gallbladder Epithelial Cells.

Authors:  Mugdha V Joglekar; Subhshri Sahu; Wilson K M Wong; Sarang N Satoor; Charlotte X Dong; Ryan J Farr; Michael D Williams; Prapti Pandya; Gaurang Jhala; Sundy N Y Yang; Yi Vee Chew; Nicola Hetherington; Dhan Thiruchevlam; Sasikala Mitnala; Guduru V Rao; Duvvuru Nageshwar Reddy; Thomas Loudovaris; Wayne J Hawthorne; Andrew G Elefanty; Vinay M Joglekar; Edouard G Stanley; David Martin; Helen E Thomas; David Tosh; Louise T Dalgaard; Anandwardhan A Hardikar
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.